Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.88 Mil
% of Total Estimate Gain
125.61%

Shilanski & Associates, Inc.'s Eli Lilly and Co Holding Summary

As of 2025-03-31, Shilanski & Associates, Inc. held - shares of Eli Lilly and Co(LLY), totaling N/A. This investment constitutes 0% of their stock portfolio, and Shilanski & Associates, Inc. now holds 0% of the outstanding Eli Lilly and Co(LLY) stock.

The initial trade took place in 2022Q3. And since then Shilanski & Associates, Inc. has made 6 purchases of LLY, at an average price of $365.98, for a total of 4,089.00 shares. In addition, there have been 5 sales at an average price of $825.67 for 4,089.00 shares. Based on historical transaction data and LLY's current price of $772.87, Shilanski & Associates, Inc.'s estimated gain on his LLY holdings is $1.88 Mil, reflecting a 125.61% gain to date.

Shilanski & Associates, Inc. LLY ($772.87) Holding Chart

Shilanski & Associates, Inc. LLY ($772.87) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1